Human meniscus allograft augmentation by allogeneic mesenchymal stromal/stem cell injections
Struijk C., Van Genechten W., Verdonk P., Krych AJ., Dietz AB., van Wijnen AJ.
Laboratory Study on Meniscus Injury, published in J Orthop Res (2022) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Orthop Res (2022)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 33969529
- PMCID
- PMC8578587
- DOI
- 10.1002/jor.25074
- Citations
- 9
Abstract (original English)
Meniscus allograft transplantations (MATs) represent established surgical procedures with proven outcomes. Yet, storage as frozen specimens and limited cellular repopulation may impair graft viability. This proof-of-concept study tests the feasibility of injecting allogeneic mesenchymal stromal/stem cells (MSCs) in meniscus allograft tissue. We investigated the injectable cell quantity, survival rate, migration, and proliferation ability of MSCs up to 28 days of incubation. In this controlled laboratory study, seven fresh-frozen human allografts were injected with human allogeneic MSCs. Cells were labeled and histological characteristics were microscopically imaged up to 28 days. Mock-injected menisci were included as negative controls in each experiment. Toluidine blue staining demonstrated that a 100-µl volume can be injected while retracting and rotating the inserted needle. Immediately after injection, labeled MSCs were distributed throughout the injection channel and eventually migrated into the surrounding tissues. Histological assessment revealed that MSCs cluster in disc-like shapes, parallel to the intrinsic lamination of the meniscus and around the vascular network. Quantification showed that more than 60% of cells were present in horizontally injected grafts and more than 30% were observed in vertically injected samples. On Day 14, cells adopted a spindle-shaped morp
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Optimizing Meniscus Allograft Transplantation - Reducing Extrusion and Restoring Joint Loading Mechanics: A Systematic Review
Systematic Review on Osteoarthritis, Meniscus Injury, published in Curr Rev Musculoskelet Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Rev Musculoskelet Med - Level ASystematic ReviewEurope PMC
Emerging biologic augmentation strategies for meniscal repair: a systematic review
Systematic Review with a reported sample of 18 on Meniscus Injury, Chronic Wound, published in BMC Musculoskelet Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 18
BMC Musculoskelet Disord7 citations - Level ASystematic ReviewEurope PMC
Osteoarthritis After Anterior Cruciate Ligament Reconstruction: A Systematic Review of Contributing Factors and Potential Treatments
Systematic Review on Osteoarthritis, Meniscus Injury, Ligament Injury, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level ASystematic ReviewPubMed
Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.
Systematic Review on Osteoarthritis, Meniscus Injury, published in Knee Surg Sports Traumatol Arthrosc (2022) — summary generated from the PubMed abstract.
- 2022
Knee Surg Sports Traumatol Arthrosc40 citations - Level ASystematic ReviewPubMed
Cell-based therapy in soft tissue sports injuries of the knee: a systematic review.
Systematic Review with a reported sample of 9 on Osteoarthritis, Meniscus Injury, Tendon Injury, Ligament Injury, published in Expert Opin Biol Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 9
Expert Opin Biol Ther10 citations - Level ASystematic ReviewPubMed
Stem cells application in meniscal tears: a systematic review of pre-clinical and clinical evidence.
Systematic Review on Meniscus Injury, published in Eur Rev Med Pharmacol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Eur Rev Med Pharmacol Sci